| Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura M Scully, SR Cataland, F Peyvandi, P Coppo, P Knöbl, ... New England Journal of Medicine 380 (4), 335-346, 2019 | 846 | 2019 |
| ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 working group R Goel, EM Bloch, F Pirenne, AZ Al‐Riyami, E Crowe, L Dau, K Land, ... Vox sanguinis 116 (8), 849-861, 2021 | 170 | 2021 |
| BNT162b2 COVID‐19 vaccine is significantly less effective in patients with hematologic malignancies K Herzog Tzarfati, O Gutwein, A Apel, N Rahimi‐Levene, M Sadovnik, ... American Journal of Hematology 96 (10), 1195-1203, 2021 | 162 | 2021 |
| Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma Y Maor, D Cohen, N Paran, T Israely, V Ezra, O Axelrod, E Shinar, M Izak, ... EClinicalMedicine 26, 2020 | 77 | 2020 |
| Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia L Shvidel, M Shtalrid, O Bairey, N Rahimi-Levene, G Lugassy, ... Leukemia & lymphoma 44 (11), 1947-1950, 2003 | 63 | 2003 |
| Acquired thrombotic thrombocytopenic purpura: a rare disease associated with BNT162b2 vaccine H Maayan, I Kirgner, O Gutwein, K Herzog‐Tzarfati, N Rahimi‐Levene, ... Journal of Thrombosis and Haemostasis 19 (9), 2314-2317, 2021 | 56 | 2021 |
| Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group T Tadmor, L Shvidel, N Goldschmidt, R Ruchlemer, R Fineman, O Bairey, ... Anticancer research 34 (2), 785-790, 2014 | 48 | 2014 |
| Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre … MA Dimopoulos, PG Richardson, NJ Bahlis, S Grosicki, M Cavo, ... The Lancet Haematology 9 (6), e403-e414, 2022 | 41 | 2022 |
| Richter's transformation to diffuse large B‐cell lymphoma: A retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the … T Tadmor, L Shvidel, O Bairey, N Goldschmidt, R Ruchlemer, R Fineman, ... American journal of hematology 89 (11), E218-E222, 2014 | 41 | 2014 |
| Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group L Shvidel, T Tadmor, A Braester, O Bairey, N Rahimi‐Levene, ... European journal of haematology 93 (1), 29-33, 2014 | 39 | 2014 |
| International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic AZ Al‐Riyami, T Burnouf, EM Wood, DV Devine, A Oreh, TO Apelseth, ... Vox sanguinis 117 (6), 822-830, 2022 | 38 | 2022 |
| The onset of p53-dependent apoptosis plays a role in terminal differentiation of human normoblasts S Peller, J Frenkel, T Lapidot, J Kahn, N Rahimi-Levene, R Yona, ... Oncogene 22 (30), 4648-4655, 2003 | 38 | 2003 |
| Blood bank protocols for large‐scale civilian casualty events: experience from terrorist bombing in Israel EJ Dann, L Bonstein, L Arbov, A Kornberg, N Rahimi‐Levene Transfusion medicine 17 (2), 135-139, 2007 | 37 | 2007 |
| Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: Mechanism of activation … A Kornberg, N Rahimi‐Levene, R Yona, A Mor, EA Rachmilewitz American journal of hematology 56 (1), 5-11, 1997 | 36 | 1997 |
| Effects of intravenous administration of tranexamic acid on hematological, hemostatic, and thromboelastographic analytes in healthy adult dogs E Kelmer, G Segev, V Papashvilli, N Rahimi‐Levene, Y Bruchim, I Aroch, ... Journal of Veterinary Emergency and Critical Care 25 (4), 495-501, 2015 | 35 | 2015 |
| Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL … L Shvidel, T Tadmor, A Braester, O Bairey, N Rahimi-Levene, ... Annals of hematology 92, 661-667, 2013 | 33 | 2013 |
| JAK2V617F allele burden is associated with transformation to myelofibrosis M Koren-Michowitz, J Landman, Y Cohen, N Rahimi-Levene, O Salomon, ... Leukemia & Lymphoma 53 (11), 2210-2213, 2012 | 32 | 2012 |
| Vox Sanguinis international forum on transfusion services' response to COVID‐19: summary MH Yazer, B Jackson, M Pagano, N Rahimi‐Levene, V Peer, JL Bueno, ... Vox Sanguinis 115 (6), 536, 2020 | 31* | 2020 |
| Analysis of red cell mass and plasma volume in patients with polycythemia M Lorberboym, N Rahimi-Levene, H Lipszyc, CK Kim Archives of pathology & laboratory medicine 129 (1), 89-91, 2005 | 31 | 2005 |
| O–product transfusion, inventory management, and utilization during shortage: the OPTIMUS study NM Dunbar, MH Yazer, ... Transfusion 58 (6), 1348-1355, 2018 | 28 | 2018 |
